Systematic study of association of four GABAergic genes: Glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABAB receptor 1 gene and GABAA receptor subunit β2 gene, with schizophrenia using a universal DNA microarray

Schizophrenia Research

Volumn 93, Issue 1-3, 2007, Pages 374-384

  Zhao, Xu ^a,b   Qin, Shengying ^a,b   Shi, Yongyong ^a,b   Zhang, Aiping ^a,b   Zhang, Jing ^a,b   Bian, Li ^b   Wan, Chunling ^a,b   Feng, Guoyin ^c   Gu, Niufan ^c   Zhang, Guangqi ^d   He, Guang ^a,b   He, Lin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

^d Shanghai Zhabei Institute of Mental Health   (China)

Author keywords

Association study; DNA microarray; Electrophoretic mobility shift assay; GABAergic system; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; GLUTAMATE DECARBOXYLASE; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GABAERGIC SYSTEM; GEL MOBILITY SHIFT ASSAY; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GABA-A; RECEPTORS, GABA-B; SCHIZOPHRENIA;

EID: 34249341163     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.02.023     Document Type: Article

References (51)

1. Addington A.M., Gornick M., Duckworth J., Sporn A., Gogtay N., Bobb A., Greenstein D., Lenane M., Gochman P., Baker N., Balkissoon R., Vakkalanka R.K., Weinberger D.R., Rapoport J.L., and Straub R.E. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol. Psychiatry 10 (2005) 581-588
2. Akbarian S., Huntsman M.M., Kim J.J., Tafazzoli A., Potkin S.G., Bunney Jr. W.E., and Jones E.G. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb. Cortex 5 (1995) 550-560
3. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., and Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52 (1995) 258-266
4. Ardlie K.G., Lunetta K.L., and Seielstad M. Testing for population subdivision and association in four case-control studies. Am. J. Hum. Genet. 71 2 (2002) 304-311
5. Bailey M.E., Albrecht B.E., Johnson K.J., and Darlison M.G. Genetic linkage and radiation hybrid mapping of the three human GABA(C) receptor rho subunit genes: GABRR1, GABRR2 and GABRR3. Biochim. Biophys. Acta 1447 (1999) 307-312
6. Benes F.M., and Berretta S. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann. N.Y. Acad. Sci. 911 (2000) 293-304
7. Benes F.M., Vincent S.L., Alsterberg G., Bird E.D., and SanGiovanni J.P. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12 (1992) 924-929
8. Benes F.M., Vincent S.L., Marie A., and Khan Y. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75 (1996) 1021-1031
9. Berretta S., Lange N., Bhattacharyya S., Sebro R., Garces J., and Benes F.M. Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons. Hippocampus 14 (2004) 876-894
10. Boutin P., Dina C., Vasseur F., Dubois S., Corset L., Seron K., Bekris L., Cabellon J., Neve B., Vasseur-Delannoy V., Chikri M., Charles M.A., Clement K., Lernmark A., and Froguel P. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol. 1 (2003) E68
11. Carrasquillo M.M., McCallion A.S., Puffenberger E.G., Kashuk C.S., Nouri N., and Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat. Genet. 32 (2002) 237-244
12. Chen W.Y., Duan S.W., Zhou J., Sun Y., Zheng Y.L., Gu N.F., Feng G.Y., and He L. A case-control study provides evidence of association for a functional polymorphism - 197C/G in XBP1 to schizophrenia and suggests a sex-dependent effect. Biochem. Biophys. Res. Commun. 319 (2004) 866-870
13. Chen W.Y., Gu N.F., Duan S.W., Sun Y., Zheng Y.L., Li C., Pan Y.X., Xu Y.F., Feng G.Y., and He L. No association between the genetic polymorphisms within RTN4 and schizophrenia in the Chinese population. Neurosci. Lett. 365 (2004) 23-27
14. Chen W.Y., Shi Y.Y., Zheng Y.L., Zhao X.Z., Zhang G.J., Chen S.Q., Yang P.D., and He L. Case-control study and transmission disequilibrium test provide consistent evidence for association between schizophrenia and genetic variation in the 22q11 gene ZDHHC8. Hum. Mol. Genet. 23 (2004) 2991-2995
15. Cho Y.M., Ritchie M.D., Moore J.H., Park J.Y., Lee K.U., Shin H.D., Lee H.K., and Park K.S. Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia 47 (2004) 549-554
16. De Luca V., Muglia P., Masellis M., Jane Dalton E., Wong G.W., and Kennedy J.L. Polymorphisms in glutamate decarboxylase genes: analysis in schizophrenia. Psychiatr. Genet. 14 (2004) 39-42
17. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., and Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr. Res. 72 (2005) 109-122
18. Goei V.L., Choi J., Ahn J., Bowlus C.L., Raha-Chowdhury R., and Gruen J.R. Human gamma-aminobutyric acid B receptor gene: complementary DNA cloning, expression, chromosomal location, and genomic organization. Biol. Psychiatry 44 (1998) 659-666
19. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., and Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57 (2000) 1061-1069
20. Heldt S.A., Green A., and Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 29 (2004) 1610-1619
21. Hisama F.M., Gruen J.R., Choi J., Huseinovic M., Grigorenko E.L., Pauls D., Mattson R.H., Gelernter J., Wood F.B., and Goei V.L. Human GABA(B) receptor 1 gene: eight novel sequence variants. Human Mutat. 17 (2001) 349-350
22. Hosak L., and Libiger J. Antiepileptic drugs in schizophrenia: a review. Eur. Psychiatry 17 (2002) 371-378
23. Ishikawa M., Mizukami K., Iwakiri M., Hidaka S., and Asada T. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci. Res. 50 (2004) 77-84
24. Johnson G.C., Payne F., Nutland S., Stevens H., Tuomilehto-Wolf E., Tuomilehto J., and Todd J.A. A comprehensive, statistically powered analysis of GAD2 in type 1 diabetes. Diabetes 51 (2002) 2866-2870
25. Lappalainen J., Sanacora G., Kranzler H.R., Malison R., Hibbard E.S., Price L.H., Krystal J., and Gelernter J. Mutation screen of the glutamate decarboxylase-67 gene and haplotype association to unipolar depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 124 (2004) 81-86
26. Laprade N., and Soghomonian J.J. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse 33 (1999) 36-48
27. Liu J., Shi Y., Tang W., Guo T., Li D., Yang Y., Zhao X., Wang H., Li X., Feng G., Gu N., Zhu S., Liu H., Guo Y., Shi J., Sang H., Yan L., and He L. Positive association of the human GABA-A-receptor beta 2 subunit gene haplotype with schizophrenia in the Chinese Han population. Biochem. Biophys. Res. Commun. 334 (2005) 817-823
28. Liu W., Innocenti F., Wu M.H., Desai A.A., Dolan M.E., Cook Jr. E.H., and Ratain M.J. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res. 65 (2005) 46-53
29. Lo W.S., Lau C.F., Xuan Z., Chan C.F., Feng G.Y., He L., Cao Z.C., Liu H., Luan Q.M., and Xue H. Association of SNPs and haplotypes in GABAA receptor beta2 gene with schizophrenia. Mol. Psychiatry 9 (2004) 603-608
30. Macdonald R.L., and Olsen R.W. GABAA receptor channels. Annu. Rev. Neurosci. 17 (1994) 569-602
31. Moore J.H., and Williams S.M. New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 34 (2002) 88-95
32. Petryshen T.L., Middleton F.A., Tahl A.R., Rockwell G.N., Purcell S., Aldinger K.A., Kirby A., Morley C.P., McGann L., Gentile K.L., Waggoner S.G., Medeiros H.M., Carvalho C., Macedo A., Albus M., Maier W., Trixler M., Eichhammer P., Schwab S.G., Wildenauer D.B., Azevedo M.H., Pato M.T., Pato C.N., Daly M.J., and Sklar P. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol. Psychiatry 10 1074-1088 (2005) 1057
33. Pitarque M., von Richter O., Rodriguez-Antona C., Wang J., Oscarson M., and Ingelman-Sundberg M. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity. Human Mutat. 23 (2004) 258-266
34. Purcell S., Cherny S.S., and Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 1 (2003) 149-150
35. Qin S., Zhao X., Pan Y., Liu J., Feng G., Fu J., Bao J., Zhang Z., and He L. An association study of the N-methyl-d-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. Eur. J. Hum. Genet. 13 (2005) 807-814
36. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., and Moore J.H. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69 (2001) 138-147
37. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
38. Tang J.X., Chen W.Y., He G., Zhou J., Gu N.F., Feng G.Y., and He L. Polymorphisms within 5′end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol. Psychiatry 9 (2004) 11-12
39. Tokuhiro S., Yamada R., Chang X., Suzuki A., Kochi Y., Sawada T., Suzuki M., Nagasaki M., Ohtsuki M., Ono M., Furukawa H., Nagashima M., Yoshino S., Mabuchi A., Sekine A., Saito S., Takahashi A., Tsunoda T., Nakamura Y., and Yamamoto K. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35 (2003) 341-348
40. Tsai C.T., Lai L.P., Lin J.L., Chiang F.T., Hwang J.J., Ritchie M.D., Moore J.H., Hsu K.L., Tseng C.D., Liau C.S., and Tseng Y.Z. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
41. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., and Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57 (2000) 237-245
42. Wacholder S., Rothman N., and Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J. Natl. Cancer Inst. 92 (2000) 1151-1158
43. Wang H., Parry S., Macones G., Sammel M.D., Ferrand P.E., Kuivaniemi H., Tromp G., Halder I., Shriver M.D., Romero R., and Strauss J.F. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM). Hum. Mol. Genet. 13 (2004) 2659-2669
44. Wang X.Y., He G., Gu N.F., Yang J.D., Tang J.X., Chen Q., Liu X.M., Shen Y.F., Qian X.Q., Lin W., Duan Y., Feng G.Y., and He L. Association of G72/G30 with Schizophrenia in the Chinese population. Biochem. Biophys. Res. Commun. 319 (2004) 1281-1286
45. West A.B., Maraganore D., Crook J., Lesnick T., Lockhart P.J., Wilkes K.M., Kapatos G., Hardy J.A., and Farrer M.J. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum. Mol. Genet. 11 (2002) 2787-2792
46. Xing Q.H., Wu S.N., Lin Z.G., Li H.F., Yang J.D., Feng G.Y., Wang M.T., Yang W.W., and He L. Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene in schizophrenia. Schizophr. Res. 65 (2003) 9-14
47. Xu Q., Jia Y.B., Zhang B.Y., Zou K., Tao Y.B., Wang Y.P., Qiang B.Q., Wu G.Y., Shen Y., Ji H.K., Huang Y., Sun X.Q., Ji L., Li Y.D., Yuan Y.B., Shu L., Yu X., Shen Y.C., Yu Y.Q., and Ju G.Z. Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders. Mol. Psychiatry 9 (2004) 510-521
48. Zai G., King N., Wong G.W., Barr C.L., and Kennedy J.L. Possible association between the gamma-aminobutyric acid type B receptor 1 (GABBR1) gene and schizophrenia. Eur. Neuropsychopharmacol. 15 (2005) 347-352
49. Zhang B.F., Tan Z., Zhang C.S., Shi Y.Y., Lin Z.X., Gu N.F., Feng G.Y., and He L. Polymorphisms of chromogranin B gene associated with schizophrenia in Chinese Han population. Neurosci. Lett. 323 (2002) 229-233
50. Zhang W.N., Bast T., and Feldon J. Prepulse inhibition in rats with temporary inhibition/inactivation of ventral or dorsal hippocampus. Pharmacol. Biochem. Behav. 73 (2002) 929-940
51. Zheng Y.L., Li H.F., Qin W., Chen W.Y., Duan Y., Xiao Y., Li C., Zhang J., Li X.W., Feng G.Y., and He L. Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population. Biochem. Biophys. Res. Commun. 328 (2005) 809-815